CARMEL,
Ind., March 4, 2024 /PRNewswire/ -- Syra Health
Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare
technology company with a mission to improve healthcare by
providing innovative services and technology solutions, announced
today a one-year, $660,000 contract
with a national healthcare organization.
As per the agreement, Syra Health will provide Healthcare
Effectiveness Data and Information Set (HEDIS®) outreach and
support services essential for fostering positive health outcomes
and reducing costs. Developed and maintained by the National
Committee for Quality Assurance (NCQA), HEDIS plays a critical role
in healthcare quality measurement and improvement initiatives. Syra
Health will leverage its team of population health experts to
collect data and acquire information from the Indiana population, including Medicaid
members, hospitals, and physicians.
"The need for robust data and analytics by healthcare
decision-makers is continuing to expand," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "We are proud that we are being
recognized for our strong team of health experts."
"We remain steadfast in pursuing and securing important
contracts for our services and products," said Sandeep Allam, Executive Chairman and President,
Syra Health. "Our contract pipeline
is growing, and we look forward to sharing more contracts as they
are fully executed."
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company addressing some
of healthcare's most significant challenges in areas such as
behavioral and mental health, digital health, and population
health, by providing innovative services and technology solutions.
Syra Health's products and services are centered on prevention,
improved access, and affordable care. Syra Health supplies its
solutions to payers, providers, life sciences organizations,
academic institutions, and the government. For more information,
please visit www.syrahealth.com.
Forward-Looking Statements
Statements in this press
release about future expectations, plans, and prospects, as well as
any other statements regarding matters that are not historical
facts, may constitute "forward-looking statements." These
statements include but are not limited to, statements relating to
the expected use of proceeds, the Company's operations and business
strategy, and the Company's expected financial results. The words
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "plan," "potential," "predict," "project,"
"should," "target," "will," "would" and similar expressions are
intended to identify forward-looking statements, although not all
forward-looking statements contain these identifying words. The
forward-looking statements contained in this press release are
based on management's current expectations and are subject to
substantial risks, uncertainty, and changes in circumstances.
Investors should read the risk factors outlined in our registration
statement on Form S-1 and other periodic reports filed with the
Securities and Exchange Commission. Any forward-looking statements
contained in this press release speak only as of the date hereof,
and, except as required by federal securities laws, the Company
specifically disclaims any obligation to update any forward-looking
statements, whether as a result of new information, future events,
or otherwise.
For more information, please contact:
For Media Inquiries:
Christine Drury
Communications & Marketing Director
Syra Health
463-345-5180
christined@syrahealth.com
For Investor Inquiries:
Ben
Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/syra-health-wins-a-contract-worth-over-650-000-focused-on-healthcare-quality-improvement-302078488.html
SOURCE Syra Health
